TARIS Biomedical Raises $15 Million
TARIS Biomedical, a Lexington, Mass.-based drug/device convergence company formed by a team of MIT scientists, has raised $15 million in Series A funding. Backers include Flagship Ventures, Flybridge Capital Partners and Polaris Venture Partners.
24 June 2009•4 mins read
